Drug
Idp 120
Idp 120: highest development phase Phase 3, developed by Bausch Health. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| IDP-120 Gel NCT03664752 | Phase 3 | Acne Vulgaris |
| IDP-120 Gel NCT03664739 | Phase 3 | Acne Vulgaris |
| IDP-120 Gel NCT03003247 | Phase 2 | Acne Vulgaris |
Latest
No recent events.
Follow Idp 120 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.